Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas

This publication has 32 references indexed in Scilit:

• Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability.
  Molecular Pharmacology, 1993
• Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma
  The Lancet, 1992
• Hypercalcemia in idiopathic myelofibrosis: Modulation of calcium and collagen homeostasis by 1,25-dihydroxyvitamin D3
  American Journal of Hematology, 1992
• A randomized prospective clinical trial to determine the efficacy of interferon-γ in severely injured patients
  The American Journal of Surgery, 1992
• Hypercalcemia and vitamin d metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship?
  Cancer, 1989
• Immunosuppressive potential of antimalarials
  The American Journal of Medicine, 1983
• LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES
  The Lancet, 1983
• Incidence of Hypercalcemia and Malignant Neoplasm
  Archives of Surgery, 1980
• Hypercalcämie bei Lymphogranulomatose
  Verhandlungen der Deutschen Gesellschaft für innere Medizin, 1965
• Hypercalcemia in malignant disease without evidence of bone destruction
  The American Journal of Medicine, 1956